What laboratory tests are recommended for a 46-year-old male with anxiety and depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Laboratory Tests for a 46-Year-Old Male with Anxiety and Depression

For a 46-year-old male presenting with anxiety and depression, a comprehensive laboratory evaluation should include thyroid function tests, complete blood count, comprehensive metabolic panel, and screening for substance use, as these can identify medical causes that may contribute to or exacerbate psychiatric symptoms.

Initial Laboratory Evaluation

Essential Laboratory Tests

  • Complete blood count (CBC) with differential

    • Identifies anemia, infection, or other hematologic abnormalities that may present with fatigue or mood symptoms

  • Comprehensive metabolic panel (CMP)

    • Assesses liver and kidney function
    • Electrolyte imbalances that may contribute to mood symptoms
    • Glucose levels to rule out diabetes or hypoglycemia

  • Thyroid function tests

    • TSH and free T4
    • Thyroid dysfunction can present with anxiety and depression 1, 2, 3
    • Subclinical hypothyroidism has been found in depressed patients 4

  • Morning cortisol with ACTH

    • Evaluates HPA axis function, which is often dysregulated in anxiety and depression 5, 3

Additional Recommended Tests

  • C-reactive protein (CRP)

    • Inflammation marker that may be elevated in depression 1

  • Vitamin B12 and folate levels

    • Deficiencies can contribute to depression symptoms

  • Vitamin D level

    • Deficiency associated with depression

  • Urine toxicology screen

    • To rule out substance-induced mood disorders

Specialized Testing Based on Clinical Presentation

  • HbA1c

    • If diabetes is suspected

  • Lipid panel

    • Cardiovascular risk assessment, as depression is associated with increased cardiovascular risk

  • Testosterone level

    • For men with concurrent sexual dysfunction or decreased libido

Assessment Tools for Anxiety and Depression

Depression Screening

  • Patient Health Questionnaire (PHQ-9)

    • Self-report scale assessing symptoms of major depressive disorder 6, 1
    • Evaluates depressive symptoms and functional impairment

  • Beck Depression Inventory (BDI)

    • Scores ≥20 suggest clinical depression 6
    • Assesses behavioral, cognitive, and somatic components of depression

Anxiety Screening

  • Generalized Anxiety Disorder (GAD-7)

    • Scores ≥5,10, and 15 indicate mild, moderate, and severe anxiety, respectively 6
    • Specifically assesses GAD symptomatology

  • Hospital Anxiety and Depression Scale (HADS)

    • Score ≥8 on either scale indicates clinically significant anxiety or depression 6
    • Advantage: excludes physical symptom items that might be confounded with medical conditions

Clinical Considerations

Comorbidity Assessment

  • Anxious depression (comorbid anxiety and depression) is common and associated with:
    • More severe symptoms
    • Higher risk of suicidal ideation
    • Poorer treatment outcomes 5
    • Different neurobiological profiles compared to non-anxious depression

Cognitive Function Evaluation

  • Consider Cognitive and Physical Functioning Questionnaire (CPFQ) to assess cognitive symptoms 1
  • Approximately 30% of patients who respond to antidepressants still report cognitive symptoms 1

Common Pitfalls to Avoid

  1. Overlooking medical causes of psychiatric symptoms

    • Always rule out medical conditions before attributing symptoms solely to psychiatric disorders

  2. Focusing only on mood symptoms

    • Cognitive symptoms can persist even after mood improves and significantly impact quality of life 1

  3. Excessive laboratory testing

    • While thyroid screening is common, overt thyroid disease is rare among depressed patients (0.4% for hyperthyroidism, no overt cases of hypothyroidism in one study) 4

  4. Missing substance use disorders

    • Alcohol and other substances can cause or exacerbate mood and anxiety symptoms 2

By following this laboratory evaluation approach, clinicians can identify potential medical contributors to anxiety and depression symptoms in a 46-year-old male, leading to more targeted and effective treatment strategies.

References

1
Guideline

Cognitive Functioning in Major Depressive Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4
Research

Routine screening of thyroid function in patients hospitalized for major depression or dysthymia?

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1995

6
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Is crexont effective for managing depression and anxiety?
What initial laboratory tests and treatments are recommended for patients presenting with depression?
What is the most likely diagnosis for an 11-year-old female with a history of suicidal attempts, depressive symptoms, anxiety, and physical and emotional abuse?
Is it common for a 20-year-old autistic female, taking Lexapro (escitalopram) and Tandospirone (sedative anxiolytic), to experience waves of sadness, depression, and mood fluctuations during the luteal phase, and can Selective Serotonin Reuptake Inhibitor (SSRI) intake exacerbate mood and anxiety symptoms?
What medication is recommended for a 36-year-old male with symptoms of anger, depression, schizophrenia, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), and Attention Deficit Disorder (ADD)?
Can a patient with Chronic Kidney Disease (CKD) stage 3 undergo a Computed Tomography Angiography (CTA) of the abdomen?
What is the use of Tolvaptan (vasopressin receptor antagonist) in treating hyponatremia?
What is the recommended diagnostic approach for a suspected Strasberg-Bismuth Type B injury when Endoscopic Retrograde Cholangiopancreatography (ERCP) appears normal?
What vitamins and supplements should all End-Stage Renal Disease (ESRD) patients take?
Will Glucagon-like peptide-1 (GLP-1) receptor agonists, such as liraglutide (Victoza) (liraglutide) and semaglutide (Ozempic) (semaglutide), be decreasing in price?
What is the management plan for a patient on an event monitor?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question